143 related articles for article (PubMed ID: 27234378)
1. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
[TBL] [Abstract][Full Text] [Related]
2. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
3. The association of
Andrzejczak A; Partyka A; Wiśniewski A; Porębska I; Pawełczyk K; Ptaszkowski K; Kuśnierczyk P; Jasek M; Karabon L
Front Immunol; 2022; 13():1006639. PubMed ID: 36741370
[TBL] [Abstract][Full Text] [Related]
4. Association of BTLA rs1982809 polymorphism with lung cancer risk in Tunisian population.
Khadhraoui C; Kaabachi W; Tritar F; Daghfous H; Hamzaoui K; Hamzaoui A
Int J Immunogenet; 2020 Dec; 47(6):554-562. PubMed ID: 32757486
[TBL] [Abstract][Full Text] [Related]
5. Gene polymorphisms of novel immunotolerant molecule BTLA: distribution of alleles, genotypes and haplotypes in Polish Caucasian population.
Partyka A; Woszczyk D; Strzała T; Szczepańska A; Tomkiewicz A; Frydecka I; Karabon L
Arch Immunol Ther Exp (Warsz); 2015 Feb; 63(1):73-8. PubMed ID: 25182981
[TBL] [Abstract][Full Text] [Related]
6. Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma - results of a prospective cohort study.
Tupikowski K; Partyka A; Pawlak EA; Ptaszkowski K; Zdrojowy R; Frydecka I; Hałoń A; Karabon L
Arch Med Sci; 2023; 19(5):1454-1462. PubMed ID: 37732048
[TBL] [Abstract][Full Text] [Related]
7. Association of
Wang J; Chen Z; Cao R; Zhang Q; Chen T; You C; Tang W; Chen S
Biomed Res Int; 2021; 2021():9121824. PubMed ID: 33564688
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
9. Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province.
Fu Z; Li D; Jiang W; Wang L; Zhang J; Xu F; Pang D; Li D
Breast Cancer Res Treat; 2010 Feb; 120(1):195-202. PubMed ID: 19585237
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
11. The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection.
Tang J; Fei J; Gu C; Liu W; Li M; Zhou C
Cell Physiol Biochem; 2018; 45(6):2540-2547. PubMed ID: 29558758
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
13. Association between BTLA polymorphisms and susceptibility to esophageal squamous cell carcinoma in the Chinese population.
Cao R; Tang W; Chen S
J Clin Lab Anal; 2020 Jun; 34(6):e23221. PubMed ID: 32060969
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
15. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
16. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
17. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
[TBL] [Abstract][Full Text] [Related]
18. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
19. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
20. Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma.
Tang W; Chen S; Kang M; Liu J; Liu C
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31774112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
